1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Urological conditions
  5. Lower urinary tract symptoms

iTind for lower urinary tract symptoms caused by benign prostatic hyperplasia

Medtech innovation briefing [MIB306] Published: 21 September 2022

  • Overview
  • Summary
  • The technology
  • Regulatory information
  • Equality considerations
  • Clinical and technical evidence
  • Expert comments
  • Expert commentators
  • Development of this briefing
Download (PDF)

Advice

  • Next

NICE has developed a medtech innovation briefing (MIB) on iTind for lower urinary tract symptoms caused by benign prostatic hyperplasia.

NICE has also published interventional procedures guidance on prostatic urethral temporary implant insertion for lower urinary tract symptoms caused by benign prostatic hyperplasia.

What are MIBs?


  • Next